These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 734973)

  • 21. [Determination of the optimal proteolytic activity of trypsin and chymotrypsin in a combination with dimethylsulphoxide].
    Tsvetkova P; Panovi E; Vasileva L
    Stomatologiia (Sofiia); 1979; 61(1):9-14. PubMed ID: 400419
    [No Abstract]   [Full Text] [Related]  

  • 22. Proteolytic enzymes and biological inhibitors. I. Comparison between the Kunitz method and the agar gel casein precipitating reaction for determination of the activity of some commercial proteolytic enzymes and inhibitors.
    Fossum K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(3):350-62. PubMed ID: 4990979
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of temperature and proteolytic enzymes on the immunological properties of 2 acid neurospecific antigens].
    Berezhnoĭ GA; Belik IaV
    Ukr Biokhim Zh; 1976; 48(3):343-7. PubMed ID: 60816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in serum trypsin inhibitors induced by the administration of proteolytic enzyme tablets to surgical patients.
    Margetts G; Barber K; Christie RB; Jones WE; Bowden WT
    Br J Clin Pract; 1972 Jun; 26(6):293-8. PubMed ID: 4557898
    [No Abstract]   [Full Text] [Related]  

  • 25. [Some properties of thermolabile trypsin, plasmin and kallikrein inhibitor from rabbit blood serum].
    Paskhina TS; Shimonaeva EE
    Vopr Med Khim; 1967; 13(5):464-71. PubMed ID: 4235108
    [No Abstract]   [Full Text] [Related]  

  • 26. [Elastolytic activity in eye tissues and serum antiproteases in corneal burns].
    Chesnokova NB; Sosulina NE
    Vopr Med Khim; 1986; 32(4):110-3. PubMed ID: 3639670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in cholino- and adrenoceptors as affected by blood proteolytic enzymes].
    Panchenko AL; Kiselev VI
    Biull Eksp Biol Med; 1984 Oct; 98(10):469-71. PubMed ID: 6238636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of trypsin inhibitor of a peptide-protein nature on kallikreins from human and rabbit blood stream].
    Paskhina TS; Krinskaia AV; Zykova VP
    Biokhimiia; 1975; 40(2):302-9. PubMed ID: 1081887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Penetration of antibiotics into experimental foci of inflammation under the influence of proteolytic enzymes].
    Geĭtman IIa; kivman GIa
    Antibiotiki; 1976 Oct; 21(10):927-32. PubMed ID: 999244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease inhibitors in sera as possible indicators of familial hypothyroidism.
    Smetana S; Khalef S; Bar-Khayim Y; Birk Y
    Isr J Med Sci; 1985 Jul; 21(7):605-9. PubMed ID: 4044221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation of the drugs acting on the blood pressure to the blood pressure and blood flow volume. 1. Nikethamide, adrenaline, noradrenaline, serotonin, histamine, acetylcholine, vasopressin, kallikrein, potassium cyanide, sodium nitrite and nitroglycerin].
    Nagasawa K; Fukuda H
    Eisei Shikenjo Hokoku; 1965 Oct; 83():32-5. PubMed ID: 4962835
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of enzymes with proteolytic activity on glucide metabolism. II. Effect on blood sugar of normal subjects and diabetics of various types].
    Specchia G; Tavazzi L; Fratino P; Comeri G
    Boll Soc Ital Biol Sper; 1968 Feb; 44(4):229-31. PubMed ID: 5677855
    [No Abstract]   [Full Text] [Related]  

  • 33. [New polyvalent protease inhibitors for trypsin, chymotrypsin, plasmin and kallikreins from snails (Helix pomatia)].
    Tschesche H; Dietl T; Marx R; Fritz H
    Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):483-6. PubMed ID: 4260409
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of trypsin, kallikrein and kontrikal on the enzyme activity and cationic protein content of the blood neutrophils].
    Kharchenko VZ; Protsenko VA; Shpak SI; Kolbasin PN
    Farmakol Toksikol; 1986; 49(2):24-6. PubMed ID: 2423365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of two alpha1-protease inhibitors in rat serum.
    Rosenberg M; Roegner V; Becker FF
    Am Rev Respir Dis; 1976 Jun; 113(6):779-85. PubMed ID: 937818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local kallikrein and trypsin responses in the rat.
    Bennett AJ; West GB
    Br J Pharmacol; 1980 Aug; 69(4):625-9. PubMed ID: 6159938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum protease inhibitors in jaundice.
    Aroor AR; Pattabiraman TN
    Indian J Exp Biol; 1979 May; 17(5):503-6. PubMed ID: 521065
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of chemical modification on proteinase interaction with inhibitors, on their coagulability and acute toxicity].
    Bogacheva TI; Mirgorodskaia OA; Grinberg GE; Mikhaĭlets GA; Moskvichev BV
    Biokhimiia; 1981 May; 46(5):863-71. PubMed ID: 6170349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum protease inhibitors in EPH-gestosis].
    Warwas M; Malinowski J; Sward J
    Wiad Lek; 1983 Sep; 36(18):1519-22. PubMed ID: 6666132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kallikrein and prekallikrein content and antitryptic activity in the blood serum in serum hepatitis of varying degrees of severity].
    Iakubovskaia RI; Malyshev NA; Farber NA; Didkovskiĭ NA; Paskhina TS
    Vopr Med Khim; 1981; 27(6):804-11. PubMed ID: 6977940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.